2015, № 12 (187)

Izmailov A.S., Kotsur T.V. ANALYSIS OF THE EFFECTIVENESS OF THE DIODE LASER (0.8 μ M) IN THE MODES OF COAGULATION AND MICROPATHOLOGICAL WHEN RUNANALYSIS THE PARAMETERS OF THE EFFECT IN THE TREATMENT OF DIABETIC MACULAR EDEMADiabetic retinopathy (DR) is the leading position among other causes of blindness in the population of economically developed countries, however, the main cause of disability in diabetes is diabetic it may (DM). The effectiveness of laser photocoagulation in the treatment of DM was confirmed during a multicenter randomized study Early Treatment Diabetic Retinopathy Study (ETDRS) and currently, laser photocoagulation is the standard treatment of diabetic macular edema. However, the application of coagulation is associated with postcompletion atrophy membranes of the ocular fundus and a decrease in the sensitivity of the retina. The current standard for treatment of diabetic macular edema is laser photocoagulation in the macula, the effectiveness of which was confirmed during a multicenter study. Sub-threshold (MicroPulse) leads to the appearance of badly visible or invisible burns of the retina and is also proven effective in the treatment of diabetic macular edema if there is no Wii side effects inherent in the ETDRS method (atrophy of the pigmention of the epithelium and choroid, reducing the sensitivity of the retina). The effectiveness of micropathological may be increased when a more dense application of laser applications, however, in the modern literature is devoted to this question a few publications.Key words: diabetic maculopathy, diabetic retinopathy, diabetes of II type, microphotocoagulation, subthreshold laser coagulation.

Download

References:

1. Ахмедьянова З.У. Повреждение структур гемато–ретинального барьера при различных режимах аргоновой лазерной коагуляции сетчатки кролика / Ахмедьянова З.У. // Тезисы докл. IV Всерос. съезд офтальмологов: М., 1982. — С. 303–304.

2. Бездетко П.А. Эпидемиология и частота сахарного диабета и диабетической ретинопатии / П.А. Бездетко, Е.В. Горбачева // Междунар. эндокрин. журн. — 2006. — № 4 (6). — С. 76–80.

3. Иванишко А. Новая классификация диабетических макулопатий (ДМП), адаптированная к проблематике их лазерного лечения / А. Иванишко // Тез.докл 2–ой Евро–Азиатская конференция по офтальмохирургии. — Екатеринбург, 2001. — С. 174–175.

4. ETDRS report number 19. Early treatment diabetic retinopathy study group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescent angiographic and other retinal characteristics at baseline// Arch. Ophthalmol. — 1995. –Vol. 113, № 9. — P. 1144–1155.

5. Katoh N. Effects of laser wavelengths on experimental retinal detachments and retinal vessels / N. Katoh, G.A. Peyman // Jpn. J. Ophthalmol. — 1988. — Vol. 32. — № 2. — P.196–210.

6. Lavinsky D. et al. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for Diabetic Macular Edema// Invest. Ophthalmol. Vis. Sci. — 2011. — Vol. 52, № 7. — P. 4314-4323.

7. Lovestam–Adrian M. Photocoagulation of diabetic macular oedema–complications and visual outcome / M. Lovestam–Adrian, E. Agardh // Acta Ophthalmol Scand. –2000. –Vol.78.–No6. — P.667–671.

8. Olk R.J. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema / R.J. Olk // Ophthalmology. — 1990. — Vol.97. — P.1101–1113.

9. Olk R. J. Modified grid argon (blue–green) laser photocoagulation for diffuse diabetic macular edema / R. J. Olk // Ophthalmology. — 1986. –Vol.93. — P.938–950.

10. Roider J. Laser treatment of retinal diseases by subthreshould laser effects// Semin. Ophthalmology. — 1999. — Vol.14 — P. 19–26.

11. Roider J., Michaud N.A., Flotte T.J. et al. Response of the retinal pigment epithelium to selective photocoagulation// Arch. Ophthalmol. — 1992. — Vol.110, №12. — P. 1786–1792.

12. Schatz H. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema /H.Schatz, D. Madeira, H.R. McDonald et al. //Archives of Ophthalmology.–1991. — Vol.109. — №11.–P.1549–1551.

13. Schatz H. Cystoid maculopathy in diabetics /H. Schatz, A. Patz //Arch. Ophthamol.–1976.–V.94.–P.761–768.

14. Singh R. Advanced glycation end-products: A review / Singh R., Barden A., Mori T., Beilin L. // Diabetologia. — 2001. — Vol. 44. — P. 129–146.

15. Stewart M. Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues / M. Stewart // Curr. Diabetes Rev. — 2012. — Vol. 8. — P. 237–246

About this article

Authors: Izmaylov A.S., Kotsur T.V.

Year: 2015

Editor-in-chief

Sergey Aleksandrovich
MIROSHNIKOV

© Электронное периодическое издание: ВЕСТНИК ОГУ on-line (VESTNIK OSU on-line), ISSN on-line 1814-6465
Зарегистрировано в Федеральной службе по надзору в сфере связи, информационных технологий и массовых коммуникаций
Свидетельство о регистрации СМИ: Эл № ФС77-37678 от 29 сентября 2009 г.
Учредитель: Оренбургский государственный университет (ОГУ)
Главный редактор: С.А. Мирошников
Адрес редакции: 460018, г. Оренбург, проспект Победы, д. 13, к. 2335
Тел./факс: (3532)37-27-78 E-mail: vestnik@mail.osu.ru